Endostatin and Anastellin's Effects on Blood Vessel Growth
Author Information
Author(s): Neskey David M, Ambesi Anthony, Pumiglia Kevin M, McKeown-Longo Paula J
Primary Institution: Center for Cell Biology & Cancer Research, Albany Medical College
Hypothesis
How do endostatin and anastellin affect the growth and movement of endothelial cells?
Conclusion
Anastellin and endostatin inhibit blood vessel growth through different mechanisms, and their combined use may enhance treatment effectiveness.
Supporting Evidence
- Anastellin completely inhibited endothelial cell proliferation in response to serum stimulation.
- Both anastellin and endostatin inhibited endothelial cell migration in response to VEGF.
- Anastellin lowered basal levels of active ERK, while endostatin did not.
Takeaway
This study shows that two proteins, endostatin and anastellin, can stop the growth of blood vessels in different ways, and using them together might work even better.
Methodology
The study used cell proliferation and transwell migration assays to compare the effects of endostatin and anastellin on endothelial cells.
Limitations
The study primarily focused on human microvessel endothelial cells, which may not represent all endothelial cell types.
Participant Demographics
Human dermal microvessel endothelial cells were used in the experiments.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website